Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
e.l.f. Beauty confirms receipt of Marathon Partners' notice of board nominees » 20:45
05/28/20
05/28
20:45
05/28/20
20:45
ELF

e.l.f. Beauty

$16.59 /

-0.7 (-4.05%)

e.l.f. Beauty confirmed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELF e.l.f. Beauty
$16.59 /

-0.7 (-4.05%)

ELF e.l.f. Beauty
$16.59 /

-0.7 (-4.05%)

05/22/20 SunTrust
e.l.f. Beauty price target raised to $20 from $15 at SunTrust
04/08/20 Piper Sandler
Piper lays out winners and losers in survey of 5,200 teens
03/18/20 DA Davidson
e.l.f. Beauty price target lowered to $12 from $24.50 at DA Davidson
02/06/20 Piper Sandler
e.l.f. Beauty price target raised to $23 from $19 at Piper Sandler
ELF e.l.f. Beauty
$16.59 /

-0.7 (-4.05%)

ELF e.l.f. Beauty
$16.59 /

-0.7 (-4.05%)

ELF e.l.f. Beauty
$16.59 /

-0.7 (-4.05%)

Hot Stocks
Geron sees FY20 operating expense burn to range from $70M-75M » 16:09
05/28/20
05/28
16:09
05/28/20
16:09
GERN

Geron

$1.60 /

-0.045 (-2.74%)

The Company expects its…

The Company expects its 2020 operating expense burn to range from $70 to $75 million. This guidance reflects cash conservation measures implemented in April due to the COVID-19 pandemic, such as suspending travel and postponing a planned imetelstat proof of concept study. It also reflects new costs for startup activities associated with the planned Phase 3 clinical trial in refractory MF and additional costs for the expansion of clinical sites for the IMerge Phase 3 clinical trial.

ShowHide Related Items >><<
GERN Geron
$1.60 /

-0.045 (-2.74%)

GERN Geron
$1.60 /

-0.045 (-2.74%)

11/19/19 B. Riley FBR
B. Riley FBR resumes Geron with Buy rating, $4 price target
11/19/19 B. Riley FBR
Geron resumed with a Buy at B. Riley FBR
09/03/19 H.C. Wainwright
Geron initiated with a Buy at H.C. Wainwright
08/15/19 Cantor Fitzgerald
Geron initiated with an Overweight at Cantor Fitzgerald
GERN Geron
$1.60 /

-0.045 (-2.74%)

GERN Geron
$1.60 /

-0.045 (-2.74%)

Earnings
Geron reports Q EPS (8c), consensus (12c) » 16:08
05/28/20
05/28
16:08
05/28/20
16:08
GERN

Geron

$1.61 /

-0.03 (-1.83%)

Reports Q1 revenue $52K,…

Reports Q1 revenue $52K, consensus $50K. As of March 31, 2020, Geron had approximately $133 million in cash, cash equivalents, and current and non-current marketable securities. Based on current planning assumptions, the Company estimates these financial resources, combined with the estimated net proceeds of approximately $140 million from the recently closed public offering of securities, provide sufficient funds for the Company's operations into the second half of 2022 when top-line results for the IMerge Phase 3 clinical trial in lower risk myelodysplastic syndromes are expected, as well completion of patient enrollment for the planned Phase 3 clinical trial in refractory myelofibrosis.

ShowHide Related Items >><<
GERN Geron
$1.61 /

-0.03 (-1.83%)

GERN Geron
$1.61 /

-0.03 (-1.83%)

11/19/19 B. Riley FBR
B. Riley FBR resumes Geron with Buy rating, $4 price target
11/19/19 B. Riley FBR
Geron resumed with a Buy at B. Riley FBR
09/03/19 H.C. Wainwright
Geron initiated with a Buy at H.C. Wainwright
08/15/19 Cantor Fitzgerald
Geron initiated with an Overweight at Cantor Fitzgerald
GERN Geron
$1.61 /

-0.03 (-1.83%)

GERN Geron
$1.61 /

-0.03 (-1.83%)

Options
NVIDIA call volume above normal and directionally bullish » 10:25
05/28/20
05/28
10:25
05/28/20
10:25
NVDA

Nvidia

$345.44 /

+4.36 (+1.28%)

Bullish option flow…

Bullish option flow detected in NVIDIA with 56,383 calls trading, 2x expected, and implied vol increasing over 1 point to 45.71%. 5/29 weekly 350 calls and 5/29 weekly 355 calls are the most active options, with total volume in those strikes near 19,800 contracts. The Put/Call Ratio is 0.34. Earnings are expected on August 13th.

ShowHide Related Items >><<
NVDA Nvidia
$345.44 /

+4.36 (+1.28%)

NVDA Nvidia
$345.44 /

+4.36 (+1.28%)

05/22/20 JPMorgan
Nvidia price target raised to $405 from $305 at JPMorgan
05/22/20 Rosenblatt
Nvidia price target raised to $400 from $340 at Rosenblatt
05/22/20 Raymond James
Nvidia price target raised to $370 from $330 at Raymond James
05/22/20 Craig-Hallum
Nvidia price target raised to $335 from $300 at Craig-Hallum
NVDA Nvidia
$345.44 /

+4.36 (+1.28%)

NVDA Nvidia
$345.44 /

+4.36 (+1.28%)

NVDA Nvidia
$345.44 /

+4.36 (+1.28%)

NVDA Nvidia
$345.44 /

+4.36 (+1.28%)

Hot Stocks
Synopsys- DesignWare DDR PHY IP platform selected by Nvidia » 09:09
05/28/20
05/28
09:09
05/28/20
09:09
SNPS

Synopsys

$170.53 /

+2.02 (+1.20%)

, NVDA

Nvidia

$341.08 /

-7.74 (-2.22%)

Synopsys' (SNPS)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNPS Synopsys
$170.53 /

+2.02 (+1.20%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

SNPS Synopsys
$170.53 /

+2.02 (+1.20%)

05/27/20 UBS
Synopsys initiated with a Buy at UBS
05/21/20 Baird
Synopsys price target raised to $193 from $182 at Baird
05/21/20 JPMorgan
Synopsys price target raised to $180 from $160 at JPMorgan
05/21/20 Wells Fargo
Synopsys price target raised to $185 from $180 at Wells Fargo
NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

05/22/20 JPMorgan
Nvidia price target raised to $405 from $305 at JPMorgan
05/22/20 Rosenblatt
Nvidia price target raised to $400 from $340 at Rosenblatt
05/22/20 Raymond James
Nvidia price target raised to $370 from $330 at Raymond James
05/22/20 Craig-Hallum
Nvidia price target raised to $335 from $300 at Craig-Hallum
SNPS Synopsys
$170.53 /

+2.02 (+1.20%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

Options
Thirteen new option listings and four option delistings on May 28th » 08:30
05/28/20
05/28
08:30
05/28/20
08:30
CFRX

ContraFect

$5.35 /

-0.045 (-0.83%)

, FREQ

Frequency Therapeutics

$18.27 /

+0.8 (+4.58%)

, HARP

Harpoon Therapeutics

$21.77 /

-3.23 (-12.92%)

, HOOK

Hookipa Pharma

$11.23 /

+0.73 (+6.95%)

, HSTO

Histogen

$4.61 /

+4.054 (+729.14%)

, IFRX

InflaRx

$8.36 /

+0.2 (+2.45%)

, KNSA

Kiniksa

$20.86 /

-0.89 (-4.09%)

, KZR

Kezar Life Sciences

$5.30 /

+0.05 (+0.95%)

, LQDA

Liquidia Technologies

$9.03 /

+0.05 (+0.56%)

, OVID

Ovid Therapeutics

$5.71 /

-0.97 (-14.52%)

, PRVL

Prevail Therapeutics

$16.83 /

-0.38 (-2.21%)

, CNAT

Conatus

$0.00 /

+ (+0.00%)

, CORV

Correvio

$0.42 /

+ (+0.00%)

, CTRC

Centric Brands

$0.19 /

-0.0279 (-12.65%)

, UNT

Unit Corp.

/

+

New option listings for…

New option listings for May 28th include ContraFect (CFRX), Centric Brands Inc (CTRCQ), Frequency Therapeutics Inc (FREQ), Harpoon Therapeutics Inc (HARP), HOOKIPA Pharma Inc (HOOK), Histogen Inc (HSTO), InflaRx NV (IFRX), Kiniksa Pharmaceuticals Ltd (Class A Stock) (KNSA), Kezar Life Sciences Inc (KZR), Liquidia Technologies Inc (LQDA), Ovid Therapeutics (OVID), Prevail Therapeutics Inc (PRVL), and Unit Corp (UNTCQ). Option delistings effective May 28th include Conatus Pharmaceuticals Inc (CNAT), Correvio Pharma Corporation (CORV), Centric Brands Inc (CTRC), and Unit Corp (UNT).

ShowHide Related Items >><<
UNT Unit Corp.
/

+

PRVL Prevail Therapeutics
$16.83 /

-0.38 (-2.21%)

OVID Ovid Therapeutics
$5.71 /

-0.97 (-14.52%)

LQDA Liquidia Technologies
$9.03 /

+0.05 (+0.56%)

KZR Kezar Life Sciences
$5.30 /

+0.05 (+0.95%)

KNSA Kiniksa
$20.86 /

-0.89 (-4.09%)

IFRX InflaRx
$8.36 /

+0.2 (+2.45%)

HSTO Histogen
$4.61 /

+4.054 (+729.14%)

HOOK Hookipa Pharma
$11.23 /

+0.73 (+6.95%)

HARP Harpoon Therapeutics
$21.77 /

-3.23 (-12.92%)

FREQ Frequency Therapeutics
$18.27 /

+0.8 (+4.58%)

CTRC Centric Brands
$0.19 /

-0.0279 (-12.65%)

CORV Correvio
$0.42 /

+ (+0.00%)

CNAT Conatus
$0.00 /

+ (+0.00%)

CFRX ContraFect
$5.35 /

-0.045 (-0.83%)

CFRX ContraFect
$5.35 /

-0.045 (-0.83%)

10/02/19 Piper Sandler
Piper says design differentiates ContraFect trial from other antibiotic studies
06/11/19 Maxim
ContraFect initiated with a Buy at Maxim
FREQ Frequency Therapeutics
$18.27 /

+0.8 (+4.58%)

05/18/20 JPMorgan
JPMorgan downgrades Frequency Therapeutics on unclear data timelines
05/18/20 JPMorgan
Frequency Therapeutics downgraded to Neutral from Overweight at JPMorgan
10/28/19 JPMorgan
Frequency Therapeutics initiated with an Overweight at JPMorgan
10/28/19 Cowen
Frequency Therapeutics initiated with an Outperform at Cowen
HARP Harpoon Therapeutics
$21.77 /

-3.23 (-12.92%)

05/22/20 Piper Sandler
Harpoon Therapeutics initiated with an Overweight at Piper Sandler
04/16/20 Citi
Citi opens 'positive 90-day catalyst watch' on Harpoon Therapeutics
02/28/20
Fly Intel: Top five analyst initiations
02/27/20 SunTrust
Harpoon Therapeutics initiated with a Buy at SunTrust
HOOK Hookipa Pharma
$11.23 /

+0.73 (+6.95%)

09/27/19 H.C. Wainwright
Hookipa Pharma initiated with a Buy at H.C. Wainwright
HSTO Histogen
$4.61 /

+4.054 (+729.14%)

IFRX InflaRx
$8.36 /

+0.2 (+2.45%)

05/21/20 BMO Capital
InflaRx price target raised to $7 from $4 at BMO Capital
05/21/20 Raymond James
Raymond James doubles InflaRx price target to $20 ahead of COVID data
05/21/20 Raymond James
InflaRx price target raised to $20 from $10 at Raymond James
04/30/20 Raymond James
InflaRx upgraded to Outperform from Market Perform at Raymond James
KNSA Kiniksa
$20.86 /

-0.89 (-4.09%)

04/01/20
Fly Intel: Top five analyst initiations
04/01/20 BofA
Kiniksa initiated with a Buy at BofA
12/06/19 Goldman Sachs
Kiniksa assumed to Buy from Neutral at Goldman Sachs
08/14/19 JMP Securities
Kiniksa price target lowered to $35 from $44 at JMP Securities
KZR Kezar Life Sciences
$5.30 /

+0.05 (+0.95%)

05/05/20 H.C. Wainwright
Kezar Life Sciences price target lowered to $9 from $15 at H.C. Wainwright
07/29/19 H.C. Wainwright
Kezar Life Sciences initiated with a Buy at H.C. Wainwright
LQDA Liquidia Technologies
$9.03 /

+0.05 (+0.56%)

04/08/20 Wedbush
Liquidia Technologies price target raised to $41 from $37 at Wedbush
01/27/20 Wedbush
Liquidia NDA acceptance reduces regulatory risk, says Wedbush
12/26/19 Wedbush
Liquidia Technologies price target lowered to $37 from $50 at Wedbush
OVID Ovid Therapeutics
$5.71 /

-0.97 (-14.52%)

05/22/20 Cantor Fitzgerald
Zynerba price target raised to $21 from $12 at Cantor Fitzgerald
05/07/20 Piper Sandler
Ovid's gaboxadol data in Fragile X 'promising,' says Piper Sandler
03/30/20 Piper Sandler
Piper says Ovid data suggests potential use for soticlestat in CDD/Dup15q
09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
PRVL Prevail Therapeutics
$16.83 /

-0.38 (-2.21%)

05/14/20 Piper Sandler
Prevail's 'quiet' Q1 report 'a victory in this environment,' says Piper Sandler
04/27/20 Piper Sandler
Prevail 20% pullback brings 'unique' buying opportunity, says Piper Sandler
04/09/20
Fly Intel: Top five analyst initiations
04/09/20 Piper Sandler
Prevail Therapeutics initiated with an Overweight at Piper Sandler
CNAT Conatus
$0.00 /

+ (+0.00%)

CORV Correvio
$0.42 /

+ (+0.00%)

12/11/19 H.C. Wainwright
Correvio downgraded to Neutral from Buy at H.C. Wainwright
09/03/19 Cantor Fitzgerald
Correvio initiated with an Overweight at Cantor Fitzgerald
CTRC Centric Brands
$0.19 /

-0.0279 (-12.65%)

UNT Unit Corp.
/

+

03/20/20 Stephens
Stephens upgrades Hess, downgrades 11 others in E&P following oil's melt down
03/20/20 Stephens
Unit Corp. downgraded to Underweight from Equal Weight at Stephens
01/06/20 Raymond James
Unit Corp. downgraded at Raymond James on commodity price weakness
01/06/20 Raymond James
Unit Corp. downgraded to Underperform from Market Perform at Raymond James
UNT Unit Corp.
/

+

PRVL Prevail Therapeutics
$16.83 /

-0.38 (-2.21%)

OVID Ovid Therapeutics
$5.71 /

-0.97 (-14.52%)

LQDA Liquidia Technologies
$9.03 /

+0.05 (+0.56%)

KZR Kezar Life Sciences
$5.30 /

+0.05 (+0.95%)

KNSA Kiniksa
$20.86 /

-0.89 (-4.09%)

IFRX InflaRx
$8.36 /

+0.2 (+2.45%)

HOOK Hookipa Pharma
$11.23 /

+0.73 (+6.95%)

HARP Harpoon Therapeutics
$21.77 /

-3.23 (-12.92%)

FREQ Frequency Therapeutics
$18.27 /

+0.8 (+4.58%)

CFRX ContraFect
$5.35 /

-0.045 (-0.83%)

CORV Correvio
$0.42 /

+ (+0.00%)

LQDA Liquidia Technologies
$9.03 /

+0.05 (+0.56%)

KZR Kezar Life Sciences
$5.30 /

+0.05 (+0.95%)

KNSA Kiniksa
$20.86 /

-0.89 (-4.09%)

IFRX InflaRx
$8.36 /

+0.2 (+2.45%)

HARP Harpoon Therapeutics
$21.77 /

-3.23 (-12.92%)

CTRC Centric Brands
$0.19 /

-0.0279 (-12.65%)

CFRX ContraFect
$5.35 /

-0.045 (-0.83%)

CORV Correvio
$0.42 /

+ (+0.00%)

Yesterday
Periodicals
Marathon Partners to initiate proxy battle with e.l.f. Beauty, WSJ reports » 19:12
05/27/20
05/27
19:12
05/27/20
19:12
ELF

e.l.f. Beauty

$17.29 /

+0.6 (+3.59%)

Marathon Partners Equity…

Marathon Partners Equity Management intends to nominate three directors to the board of e.l.f. Beauty, a rare instance of an activist investor initiating a proxy battle since the COVID-19 crisis shook U.S. corporations, the Wall Street Journal's Corrie Driebusch reports. In a document viewed by the Journal, Marathon criticizes the cosmetic company's cost structure, management compensation plan, and stock performance. The activist's nominations to the board could be made public as soon as Thursday, Driebusch notes. Marathon, which has been an e.l.f. stakeholder since 2018, owns roughly 5% of the company's shares, the author says, citing people familiar with the matter. Reference Link

ShowHide Related Items >><<
ELF e.l.f. Beauty
$17.29 /

+0.6 (+3.59%)

ELF e.l.f. Beauty
$17.29 /

+0.6 (+3.59%)

05/22/20 SunTrust
e.l.f. Beauty price target raised to $20 from $15 at SunTrust
04/08/20 Piper Sandler
Piper lays out winners and losers in survey of 5,200 teens
03/18/20 DA Davidson
e.l.f. Beauty price target lowered to $12 from $24.50 at DA Davidson
02/06/20 Piper Sandler
e.l.f. Beauty price target raised to $23 from $19 at Piper Sandler
ELF e.l.f. Beauty
$17.29 /

+0.6 (+3.59%)

ELF e.l.f. Beauty
$17.29 /

+0.6 (+3.59%)

General News
Global device shipments to fall 14% due to COVID -19 impact, Gartner says » 13:00
05/27/20
05/27
13:00
05/27/20
13:00
LNVGY

Lenovo

$0.00 /

+ (+0.00%)

, HPQ

HP Inc.

$16.80 /

-0.27 (-1.58%)

, DELL

Dell Technologies

$44.88 /

+0.42 (+0.94%)

, HPE

HP Enterprise

$9.66 /

+0.25 (+2.66%)

, AAPL

Apple

$314.68 /

-2.03 (-0.64%)

, SSNLF

Samsung

$0.00 /

+ (+0.00%)

, GOOG

Alphabet

$1,410.00 /

-7.93 (-0.56%)

Global shipments of…

Global shipments of devices, PCs, tablets and mobile phones, are on pace to decline 13.6% in 2020, totaling 1.9B units, according to the latest forecast from Gartner. "The forecasted decline in the PC market in particular could have been much worse," said Ranjit Atwal, senior research director at Gartner. "However, government lockdowns due to COVID-19 forced businesses and schools to enable millions of people to work from home and increase spending on new notebooks, Chromebooks and tablets for those workers. Education and government establishments also increased spending on those devices to facilitate e-learning." In 2020, PC shipments are expected to decline 10.5% (see Table 1). Shipments of notebooks, tablets and Chromebooks are forecast to decline slower than the PC market overall in 2020.Gartner said that 48% of employees will likely work remotely at least part of the time after the COVID-19 pandemic, compared to 30% pre-pandemic. Overall, the work from home trend will make IT departments shift to more notebooks, tablets and Chrome devices for work. "This trend combined with businesses required to create flexible business continuity plans will make business notebooks displace deskbased PCs through 2021 and 2022," said Mr. Atwal. The Fly notes that companies which may be impacted by this include: Lenovo (LNVGY), HP Inc. (HPQ), Dell Technologies (DELL), HP Enterprise (HPE), Apple (AAPL) Alphabet (GOOG) Samsung (SSNLF). Reference Link

ShowHide Related Items >><<
SSNLF Samsung
$0.00 /

+ (+0.00%)

LNVGY Lenovo
$0.00 /

+ (+0.00%)

HPQ HP Inc.
$16.80 /

-0.27 (-1.58%)

HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

GOOG Alphabet
$1,410.00 /

-7.93 (-0.56%)

DELL Dell Technologies
$44.88 /

+0.42 (+0.94%)

AAPL Apple
$314.68 /

-2.03 (-0.64%)

LNVGY Lenovo
$0.00 /

+ (+0.00%)

05/21/20 JPMorgan
Lenovo downgraded to Neutral from Overweight at JPMorgan
03/27/20 Goldman Sachs
Lenovo downgraded to Neutral from Buy at Goldman Sachs
HPQ HP Inc.
$16.80 /

-0.27 (-1.58%)

05/26/20 Credit Suisse
HP Inc. price target lowered to $17 from $22 at Credit Suisse
05/22/20 JPMorgan
HP shares worth owning through downturn, says JPMorgan
04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
04/21/20 Deutsche Bank
HP Inc. price target lowered to $17 from $20 at Deutsche Bank
DELL Dell Technologies
$44.88 /

+0.42 (+0.94%)

05/27/20 BMO Capital
VMware price target lowered to $152 from $163 at BMO Capital
05/26/20 Deutsche Bank
Dell Technologies price target lowered to $52 from $56 at Deutsche Bank
05/19/20 Barclays
Barclays lowers estimates in IT hardware after April survey
04/13/20 Bernstein
Dell Technologies price target lowered to $50 from $60 at Bernstein
HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

05/27/20
Fly Intel: Top five analyst downgrades
05/27/20 Argus
HP Enterprise downgraded to Hold from Buy at Argus
05/27/20 Argus
HP Enterprise downgraded to Hold from Buy at Argus
05/26/20
Fly Intel: Top five analyst upgrades
AAPL Apple
$314.68 /

-2.03 (-0.64%)

05/27/20 BofA
Apple price target raised to $340 from $320 at BofA
05/27/20 Jefferies
Apple price target raised to $370 from $350 at Jefferies
05/27/20 Deutsche Bank
Apple price target raised to $320 from $305 at Deutsche Bank
05/26/20 Stifel
Cirrus Logic price target raised to $82 from $80 at Stifel
SSNLF Samsung
$0.00 /

+ (+0.00%)

04/24/20 Credit Suisse
Apple, Samsung smartphone production plans revised down, says Credit Suisse
03/12/20 KeyBanc
COVID-19 impacting iPhone supply, resulting in lower store traffic, says KeyBanc
02/26/20 JPMorgan
Nokia's only viable strategic options sale of company or assets, says JPMorgan
01/30/20 Craig-Hallum
Qorvo price target raised to $135 from $100 at Craig-Hallum
GOOG Alphabet
$1,410.00 /

-7.93 (-0.56%)

05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
05/07/20 Bernstein
Google payments to Apple big, predicated on advertising, says Bernstein
SSNLF Samsung
$0.00 /

+ (+0.00%)

HPQ HP Inc.
$16.80 /

-0.27 (-1.58%)

HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

GOOG Alphabet
$1,410.00 /

-7.93 (-0.56%)

DELL Dell Technologies
$44.88 /

+0.42 (+0.94%)

AAPL Apple
$314.68 /

-2.03 (-0.64%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

LNVGY Lenovo
$0.00 /

+ (+0.00%)

HPQ HP Inc.
$16.80 /

-0.27 (-1.58%)

HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

GOOG Alphabet
$1,410.00 /

-7.93 (-0.56%)

DELL Dell Technologies
$44.88 /

+0.42 (+0.94%)

AAPL Apple
$314.68 /

-2.03 (-0.64%)

SSNLF Samsung
$0.00 /

+ (+0.00%)

HPQ HP Inc.
$16.80 /

-0.27 (-1.58%)

HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

GOOG Alphabet
$1,410.00 /

-7.93 (-0.56%)

DELL Dell Technologies
$44.88 /

+0.42 (+0.94%)

AAPL Apple
$314.68 /

-2.03 (-0.64%)

HPQ HP Inc.
$16.80 /

-0.27 (-1.58%)

HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

GOOG Alphabet
$1,410.00 /

-7.93 (-0.56%)

DELL Dell Technologies
$44.88 /

+0.42 (+0.94%)

AAPL Apple
$314.68 /

-2.03 (-0.64%)

GOOG Alphabet
$1,410.00 /

-7.93 (-0.56%)

AAPL Apple
$314.68 /

-2.03 (-0.64%)

Options
Hewlett Packard Enterprise call volume above normal and directionally bullish » 10:25
05/27/20
05/27
10:25
05/27/20
10:25
HPE

HP Enterprise

$9.66 /

+0.25 (+2.66%)

Bullish option flow…

Bullish option flow detected in Hewlett Packard Enterprise with 7,584 calls trading, 6x expected, and implied vol increasing almost 6 points to 49.72%. 5/29 weekly 9.5 calls and 6/12 weekly 10 calls are the most active options, with total volume in those strikes near 4,900 contracts. The Put/Call Ratio is 0.05. Earnings are expected on August 25th.

ShowHide Related Items >><<
HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

05/27/20
Fly Intel: Top five analyst downgrades
05/27/20 Argus
HP Enterprise downgraded to Hold from Buy at Argus
05/27/20 Argus
HP Enterprise downgraded to Hold from Buy at Argus
05/26/20
Fly Intel: Top five analyst upgrades
HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

HPE HP Enterprise
$9.66 /

+0.25 (+2.66%)

Downgrade
Fly Intel: Top five analyst downgrades » 10:06
05/27/20
05/27
10:06
05/27/20
10:06
HPE

HP Enterprise

$9.64 /

+0.23 (+2.44%)

, PSO

Pearson

$5.59 /

-0.165 (-2.87%)

, H

Hyatt

$58.38 /

+1.995 (+3.54%)

, PINS

Pinterest

$19.12 /

-0.36 (-1.85%)

, MRUS

Merus

$13.95 /

-1.705 (-10.89%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HP Enterprise (HPE) downgraded to Hold from Buy at Argus with analyst Jim Kelleher saying as the company aim to address new and existing competitive threats, the aggressive cost-cutting measures risk "cutting into muscle." 2. Pearson (PSO) downgraded to Sell from Hold at Berenberg with analyst Sarah Simon saying she expects "severe disruption" to college enrollments in 2020 due to the COVID-19 and now assumes a 10% decline in the fall for Pearson. 3. Hyatt (H) downgraded to Neutral from Outperform at Baird with analyst Michael Bellisario saying the stock has rebounded some as cities and states have reopened but the higher profit segments of the industry have note reopened including business travel and group convention business. 4. Pinterest (PINS) downgraded to Hold from Buy at Argus with analyst Jim Kelleher saying the company reported slower U.S. user growth of 6% in Q1 as investors anticipated Pinterest to grow its user base more rapidly due to COVID-19's shelter in place. 5. Merus (MRUS) downgraded to Sector Perform from Outperform at RBC Capital with analyst Brian Abrahams citing the recent discontinuation of the company's key potential value driver MCLA-117 after a "long early clinical development path" due to insufficient activity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
PSO Pearson
$5.59 /

-0.165 (-2.87%)

PINS Pinterest
$19.12 /

-0.36 (-1.85%)

MRUS Merus
$13.95 /

-1.705 (-10.89%)

HPE HP Enterprise
$9.64 /

+0.23 (+2.44%)

H Hyatt
$58.38 /

+1.995 (+3.54%)

HPE HP Enterprise
$9.64 /

+0.23 (+2.44%)

05/27/20 Argus
HP Enterprise downgraded to Hold from Buy at Argus
05/27/20 Argus
HP Enterprise downgraded to Hold from Buy at Argus
05/26/20
Fly Intel: Top five analyst upgrades
05/26/20 JPMorgan
HP Enterprise upgraded to Neutral on valuation at JPMorgan
PSO Pearson
$5.59 /

-0.165 (-2.87%)

05/27/20 Berenberg
Pearson downgraded to Sell from Hold at Berenberg
04/28/20 AlphaValue
Pearson upgraded to Add from Reduce at AlphaValue
04/28/20 Barclays
Pearson price target lowered to 465 GBp from 520 GBp at Barclays
04/09/20 Societe Generale
Pearson upgraded to Buy from Hold yesterday at Societe Generale
H Hyatt
$58.38 /

+1.995 (+3.54%)

05/27/20 Baird
Hyatt downgraded to Neutral at Baird
05/27/20 Baird
Hyatt downgraded to Neutral from Outperform at Baird
05/08/20
Fly Intel: Top five analyst downgrades
05/08/20 Deutsche Bank
Hyatt price target lowered to $54 from $86 at Deutsche Bank
PINS Pinterest
$19.12 /

-0.36 (-1.85%)

05/27/20 Argus
Pinterest downgraded to Hold from Buy at Argus
05/27/20 Argus
Pinterest downgraded to Hold from Buy at Argus
05/06/20 DA Davidson
Pinterest downgraded to Neutral from Buy at DA Davidson
05/06/20 Baird
Pinterest price target lowered to $20 from $23 at Baird
MRUS Merus
$13.95 /

-1.705 (-10.89%)

05/27/20 RBC Capital
Merus downgraded to Sector Perform from Outperform at RBC Capital
05/27/20 RBC Capital
Merus downgraded to Sector Perform from Outperform at RBC Capital
11/20/19 Guggenheim
Merus assumed with a Buy at Guggenheim
06/28/19 Roth Capital
Merus initiated with a Buy at Roth Capital
PSO Pearson
$5.59 /

-0.165 (-2.87%)

PINS Pinterest
$19.12 /

-0.36 (-1.85%)

HPE HP Enterprise
$9.64 /

+0.23 (+2.44%)

H Hyatt
$58.38 /

+1.995 (+3.54%)

PSO Pearson
$5.59 /

-0.165 (-2.87%)

PINS Pinterest
$19.12 /

-0.36 (-1.85%)

HPE HP Enterprise
$9.64 /

+0.23 (+2.44%)

H Hyatt
$58.38 /

+1.995 (+3.54%)

PINS Pinterest
$19.12 /

-0.36 (-1.85%)

HPE HP Enterprise
$9.64 /

+0.23 (+2.44%)

H Hyatt
$58.38 /

+1.995 (+3.54%)

PINS Pinterest
$19.12 /

-0.36 (-1.85%)

PINS Pinterest
$19.12 /

-0.36 (-1.85%)

HPE HP Enterprise
$9.64 /

+0.23 (+2.44%)

H Hyatt
$58.38 /

+1.995 (+3.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.